Australian (ASX) Stock Market Forum

WFL - Wellfully Limited

Interesting couple of days for OBJ as it waits fro results in February:

1. Looks like The Speculator is now on the OBJ story. This might help to explain some of the latest volumes.

2. OBJ Ltd (ASX: OBJ) noted the overnight publication by the Journal of
Pharmaceutical Science of a paper into the enhanced transdermal delivery of
Naltrexone by the Companys technology.
The paper is published by Wiley Interscience and the American Pharmacists and I believe that it is a peer reviewed journal. Still no guarantees for February but slowly starts to build some credibility in the lead-up to results. Not surprised the SP rose to 3.2c on this. :)

Holding OBJ at .007c

Has anyone in here run the calcs or come across what the Feb announcment is worth to the company or beter still on a per share basis for first 12 months if it is a positive announcment.... I read somewhere its a $13.?? Billion dollar anticipated market share or industry..... but whats the rofit margin and whats the expected uptakes on this product...

Obviously by the size of OBJ is huge, but anyone found a calculation yet...
 
Has anyone recieved their rights certificate yet.....

Or does anyone know the details of how / when they are arriving, because they are due back with payment by 5pm 30th Dec 2009.....
 
Just checked comsec..... heres the details

SUMMARY OF IMPORTANT DATES
Lodgement Date
21 December 2009
”Ex” date
24 December 2009
Record date to determine Entitlement
4 January 2010
Prospectus with Application Form dispatched
7 January 2010
Closing date for acceptances
21 January 2010
Allotment and issue of New Shares and New Options
1 February 2010
Dispatch of shareholding statements
1 February 2010
Trading of New Shares and New Options expected to commence
2 February 2010
 
Hi all
Recieved OBJ rights and options letter in mail yesterday - 3 pages
Went to web site 31 page prospectus supposedly has application form attached as last page.....but it doesnt on the asx or any other site....

I have contacted OBJ director via email from the site to tbring it to his attention....

Please advise in here if you find when / where the application form is hiding, and I will do likewise....
 
Hi Condog.

Decided to sell out of OBJ and lock in a 325% profit.

The story of OBJ has much merit but I am not totally convinced about the timing of the new issue and information in the prospectus.

a. Note that OBJ seem to be budgeting for next 2 years. Guess they feel that they have to do this but not total confindence in 3M deal as yet.

b. While entitlement date was 24/12, holders don't get the shares until Feb.2.
It is quite possible that results on the trials will be known and possibly released before one gets control of their allocation. While I accept that the allocation is only small, I like to have control of my shares when sensitive news is likely. If the news is not positive...

While I can fully understand investors holding through to February, I'm happy to collect a 325% profit and lock it in for the next play. Can't go broke on 325% profits :)

Good luck to all holders and hopefully February will be a 10 bagger + for you.
 
Does anyone have any idea what brought about the recent price spike in OBJ? I bought before the ex date for the latest entitlement and was expecting the price to stay pretty low for a while due to the capital raising, atleast until the details of the companies discussions with the 3M corporation have been brought to market (I think 3M's evaluation of the OBJ transdermal drug delivery system is set to finish by the begginning of Feb). I was surprised (and pleased) to see a 20% increase yesterday, however, I still feel 20% pales in comparison to the potential upside in OBJ if the 3M deal comes to fruition because, as highlighted by the speculator, the 3M corporation has annual global sales of $US25 billion, the transdermal drug delivery market is rated by OBJ at $US13.7 billion annually and OBJ still enjoys a tiny market cap of just $AUD33M @ $0.034 - all good signs if the deal goes through. I always get suspicious when trading hikes-up pending a company announcement (particularly when the increased trading sends prices south), as people within the company would clearly have a better idea of the companies performance than outside investors. Whilst the announcement is still expected to come 2 weeks from now, increased trading volume and share price leading up to the announcement without any other recent company announcements seem to me to be great indicators of how 3M's evaluation may be going.

Obviously this is just my opinion and should not be relied upon for investing decisions.
 
Does anyone have any idea what brought about the recent price spike in OBJ? I bought before the ex date for the latest entitlement and was expecting the price to stay pretty low for a while due to the capital raising, atleast until the details of the companies discussions with the 3M corporation have been brought to market (I think 3M's evaluation of the OBJ transdermal drug delivery system is set to finish by the begginning of Feb). I was surprised (and pleased) to see a 20% increase yesterday, however, I still feel 20% pales in comparison to the potential upside in OBJ if the 3M deal comes to fruition because, as highlighted by the speculator, the 3M corporation has annual global sales of $US25 billion, the transdermal drug delivery market is rated by OBJ at $US13.7 billion annually and OBJ still enjoys a tiny market cap of just $AUD33M @ $0.034 - all good signs if the deal goes through. I always get suspicious when trading hikes-up pending a company announcement (particularly when the increased trading sends prices south), as people within the company would clearly have a better idea of the companies performance than outside investors. Whilst the announcement is still expected to come 2 weeks from now, increased trading volume and share price leading up to the announcement without any other recent company announcements seem to me to be great indicators of how 3M's evaluation may be going.

Obviously this is just my opinion and should not be relied upon for investing decisions.

yeh crazy activity given its ex entitlement now and the dilution actually devalued the shares.... One advisory service I subscribe to mentioned it in his column which is putting some people into it undoubtably...but given the volumes on a few other sotck in the same service it seems like thats what it is...
 
Comments by The Speculator - David Hasselhurst perhaps? he has added it to his portfolio in the Eureka Report


Yeah, I read his column in the Eureka Report this week and I didn't think much of it, but having re-read it, I guess it does re-highlight the importance of the 3M deal and it also states that he's willing to go into debt to participate in the 1 for 9 entitlement so I guess Speculator followers may have read this as being encouraging and since the price was lower than what he got it for, they've jumped into it.

Although, I still like to think that some of the volume is attributed to inside information about the 3M deal hehe.
 
Something must be going on. Went up 24% today and the company confirmed by annoucement that there was no reason for the increase...
 
Something must be going on. Went up 24% today and the company confirmed by annoucement that there was no reason for the increase...

i would say its the way all bio's are moving at the moment... but there's also the 3M deal we should hear news on in Feb... so could be a bit of both
 
Something must be going on. Went up 24% today and the company confirmed by annoucement that there was no reason for the increase...

Is been reccomended by a few players in the industry....but its always interesting when they go up for no reason and the company says no reason....
Youd like to get hold of the registry list for that day ay.... makes me laugh often....

If anyones reporting it they are innevitably mentioning the possibility of a 3M announcment and thas possibly huge, but like with all biotechs, it aint over till the large lady sings...Biotechs have big upside but they make me nervous because they can make it to the last hurdle and fall over on a pretty regular basis...

Disc - own some, not much, (enough to gain from possible 3m deal, but not enough to worry if it doesnt come off)
 
Its interesting that 2 drug delivery companies: OBJ and UNS are both running hard this past week. I'm not suggesting anything here, just a coincidence.
 
Hi Condog.

Decided to sell out of OBJ and lock in a 325% profit.

The story of OBJ has much merit but I am not totally convinced about the timing of the new issue and information in the prospectus.

a. Note that OBJ seem to be budgeting for next 2 years. Guess they feel that they have to do this but not total confindence in 3M deal as yet.

b. While entitlement date was 24/12, holders don't get the shares until Feb.2.
It is quite possible that results on the trials will be known and possibly released before one gets control of their allocation. While I accept that the allocation is only small, I like to have control of my shares when sensitive news is likely. If the news is not positive...

While I can fully understand investors holding through to February, I'm happy to collect a 325% profit and lock it in for the next play. Can't go broke on 325% profits :)

Good luck to all holders and hopefully February will be a 10 bagger + for you.

Here are BESBS....I will kick you so you dont have to kick yourslef.....although 325% is safer in the pocket then on the table...
 
I've looked into this company, and just don't see anything material to support the substantial price rise. Rumours are rife on HC that there has been a leak and that a deal with 3M is near. Whenever I see a certain select band of posters on HC, appearing on the same stock, my 'pump and dump' metre goes into the red, and let me tell you it is doing so at the moment. I am not saying that the price won't go further. It's just that I wouldn't be wanting to be left without a seat if the music stops.:2twocents
 
I've looked into this company, and just don't see anything material to support the substantial price rise. Rumours are rife on HC that there has been a leak and that a deal with 3M is near. Whenever I see a certain select band of posters on HC, appearing on the same stock, my 'pump and dump' metre goes into the red, and let me tell you it is doing so at the moment. I am not saying that the price won't go further. It's just that I wouldn't be wanting to be left without a seat if the music stops.:2twocents
Considering obj,s em patches are 10x more effective than any other patch arround and 3m and others are looking at obj im not suprised the sp of obj is over 5 cents atm.
A lot more upside I think as I would have sold by now if I was to think the sp was to fall but all I will be doing is buying more.
Long term it is only a matter of time before the money starts to come in and I will be holding for years to come.
 
Considering obj,s em patches are 10x more effective than any other patch arround and 3m and others are looking at obj im not suprised the sp of obj is over 5 cents atm.
A lot more upside I think as I would have sold by now if I was to think the sp was to fall but all I will be doing is buying more.
Long term it is only a matter of time before the money starts to come in and I will be holding for years to come.

Its all rumour at this stage, but i tend to agree with what your saying....it seems likely that 3m will be interested on multiple fronts and or other med co's..... if 3m lets this go.....
Looks like speculators in at the moment, but its surely due for revaluation just on the basis of how promising the technology has proven and the size of potential contracts..... Id be doubtful we will see much downside for a while.... particularly leading into feb...
 
Considering obj,s em patches are 10x more effective than any other patch arround and 3m and others are looking at obj im not suprised the sp of obj is over 5 cents atm.
A lot more upside I think as I would have sold by now if I was to think the sp was to fall but all I will be doing is buying more.
Long term it is only a matter of time before the money starts to come in and I will be holding for years to come.

I've been trying to find out as much as possible about this company, but see nothing conclusive to justify the price rise. It is interesting and I may have considered a dip except the rampers and price action has warded me off.

Serious danger signals flashing here. Good luck to the gamblers :2twocents
 
Sure there is a lot of ramping going on the obj threads on hotcopper but many of these rampers have been holders for a long time and have done a lot of research into obj,s patches.
I for one was so intersested that I went to the agm to try and find out if these rampers new what they wer talking about and much of what has been said I found to be true at the obj agm.
This is some of the points raised at the obj agm that got me so interested.
1:They are in talks with other companies
2:There patches are properly patented
3:Each electro magnetic field is patened so that no matter what field that needs to to programed for each patch, they are protected
4:Each em patch can be programed so as to suit each product being aplied on the patch as to suit peoples needs
5:Obj,s em patches are 10x more effective than any other patch neadle or pill on the market
6:We wer shown some slides explaining why obj,s patches are 10x more effective and thats other transdermal patches spread the product all arround the skin with waste and less effectiveness while obj,s em patch is dirrect useing electro magnetic feilds to inject the product meaning no waste and less product neaded
7:Obj,s plan is to get some revenue comeing in then buy products from other companies so they can market and distibute the patches on there own and also when funds permit buy out other companies but first get some income then the big plan.
8:Obj,s patened patches can be used by other companies to extend the life of there exsiting products that are about to run out of pantent saveing them millions in not needing to have to develop new products.
So you see its all about the product not a sp that is about true value considering what they have or the ramping going on, as I see current sp only a start of a revaluation of obj,s forward thinking value going forward.
I think people should have a good look at the product and talk to people in the medical industry before they jump to a opinion that obj,s sp has been ramped up as im of the opinion that obj has been udervalued for a long time.
As always dyor
 
Sure there is a lot of ramping going on the obj threads on hotcopper but many of these rampers have been holders for a long time and have done a lot of research into obj,s patches.

There is NO fundamental analysis on the HC OBJ forum. Where are the numbers? Market size? Competitors? Time to market? Margins? EPS? Production facility? etc etc. Its all complete babble on there. Infact more so than I have ever seen. It reminds me of the massive pump and dumps on HC such as CVI, IMI, EGO, SBN, RAU etc etc.

I recognize at least 15 names there who have claimed to be long term holders on other stocks also, in the last 4 years which I have frequented HC. Suffice to say that they no longer post on any of those stocks. This is a pump and dump for the consortium. At some point some are going to bail, and it will be a case of first out of the door.

As for OBJ, yes they have an interesting product, but transdermal drug delivery will take many many years to commercialize, if at all to become commonplace. There is NO need to rush into the stock. I will look at them again in a year or two.
 
Top